全文获取类型
收费全文 | 967283篇 |
免费 | 68389篇 |
国内免费 | 7320篇 |
专业分类
耳鼻咽喉 | 12871篇 |
儿科学 | 29384篇 |
妇产科学 | 27010篇 |
基础医学 | 134954篇 |
口腔科学 | 25839篇 |
临床医学 | 83863篇 |
内科学 | 193351篇 |
皮肤病学 | 19725篇 |
神经病学 | 74934篇 |
特种医学 | 38806篇 |
外国民族医学 | 377篇 |
外科学 | 148953篇 |
综合类 | 30841篇 |
现状与发展 | 17篇 |
一般理论 | 249篇 |
预防医学 | 68741篇 |
眼科学 | 21891篇 |
药学 | 70992篇 |
74篇 | |
中国医学 | 5437篇 |
肿瘤学 | 54683篇 |
出版年
2021年 | 9386篇 |
2019年 | 8704篇 |
2018年 | 11384篇 |
2017年 | 9165篇 |
2016年 | 9667篇 |
2015年 | 11808篇 |
2014年 | 16246篇 |
2013年 | 22395篇 |
2012年 | 30334篇 |
2011年 | 32796篇 |
2010年 | 19785篇 |
2009年 | 18207篇 |
2008年 | 29466篇 |
2007年 | 31151篇 |
2006年 | 31439篇 |
2005年 | 30834篇 |
2004年 | 28475篇 |
2003年 | 27603篇 |
2002年 | 26837篇 |
2001年 | 42942篇 |
2000年 | 44226篇 |
1999年 | 38147篇 |
1998年 | 11196篇 |
1997年 | 10467篇 |
1996年 | 10078篇 |
1995年 | 9325篇 |
1994年 | 8845篇 |
1993年 | 8068篇 |
1992年 | 28761篇 |
1991年 | 27474篇 |
1990年 | 26828篇 |
1989年 | 25717篇 |
1988年 | 23856篇 |
1987年 | 23422篇 |
1986年 | 22472篇 |
1985年 | 21300篇 |
1984年 | 15899篇 |
1983年 | 13538篇 |
1982年 | 8116篇 |
1979年 | 14624篇 |
1978年 | 10208篇 |
1977年 | 8627篇 |
1976年 | 8147篇 |
1975年 | 8959篇 |
1974年 | 10697篇 |
1973年 | 10182篇 |
1972年 | 9661篇 |
1971年 | 8917篇 |
1970年 | 8584篇 |
1969年 | 8025篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
R. Di Raimondo J. Sanz-Esporrn R. Pl I. Sanz-Martn F. Luengo F. Vignoletti J. Nuez Mariano Sanz 《Clinical oral investigations》2020,24(7):2351-2361
To evaluate the changes in alveolar contour after guided bone regeneration (GBR) with two different combinations of biomaterials in dehiscence defects arou 相似文献
32.
33.
F. Fruzzetti G. Palla A. Sbrana T. Simoncini M. R. Sessa 《Gynecological endocrinology》2020,36(10):938-940
AbstractObjective: To understand the origin of extremely high gonadotropin levels in a perimenopausal woman.Methods: A 52-year-old woman with a 2?months of amenorrhea followed spontaneous menstrual cycles recovery was referred to our outpatient clinic with elevated follicle-stimulating hormone (FSH, 483 mUI/ml), luteinizing hormone (LH, 475 mUI/ml) and prolactin (PRL, 173?ng/ml). She was known to take levosulpiride. The gonadotropin levels did not fit with the clinical features.Results: A gonadotroph tumor was ruled out. Further analysis confirmed constantly high FSH, LH and PRL levels. The measurements were repeated using different analytical platforms with different results. After serial dilutions, nonlinearity was present suggesting an immunoassay interference. After post-polyethylene glycol recovery, hormone levels appeared in the normal range. Anti-goat antibodies were recognized in the serum of the patient.Conclusions: This case report shows a case of falsely abnormal high gonadotropin and PRL levels in a woman during menopause transition. In the clinical practice the evaluation of gonadotropin profile is not recommended at this age, but the abnormal levels stimulated further evaluation. An interference in the assay due to anti-goat antibodies resulted in abnormally high level of FSH and LH. A strict collaboration between clinicians and the laboratory is needed, when laboratory findings do not correspond to clinical findings. 相似文献
34.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
35.
Martin F. Shapiro 《Journal of general internal medicine》2015,30(10):1392-1393
36.
37.
Gui-Qi Zhu Ke-Qing Shi Sha Huang Gui-Qian Huang Yi-Qian Lin Zhi-Rui Zhou Martin Braddock Yong-Ping Chen Ming-Hua Zheng 《Medicine》2015,94(11)
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment regimen is unclear and warrants exploration, we aimed to compare these therapies in terms of patient mortality or liver transplantation (MOLT) and adverse events (AE).PubMed, the Cochrane Library, and Scopus were searched for randomized controlled trials up to August 31, 2014. We estimated the hazard ratios (HRs) for MOLT and odds ratios (ORs) for AE. A sensitivity analysis based on the dose of UDCA was also executed.Thirty-one eligible articles were included. Compared with COT plus UDCA, UDCA (HR 0.38, 95% confidence interval [CI] 0.09–1.39), BEF plus UDCA (HR 0.29, 95% CI 0.02–4.83), COC plus UDCA (HR 0.39, 95% CI 0.07–2.25), MTX plus UDCA (HR 0.28, 95% CI 0.05–1.63), or OBS (HR 0.49, 95% CI 0.11–2.01) all provided an increased risk of MOLT. With respect to drug AE profile, although not differing appreciably, BEF plus UDCA was associated with more AEs compared with UDCA (OR 3.16, 95% CI 0.59–20.67), COT plus UDCA (OR 2.27, 95% CI 0.15–33.36), COC plus UDCA (OR 1.00, 95% CI 0.09–12.16), MTX plus UDCA (OR 2.03, 95% CI 0.23–17.82), or OBS (OR 3.00, 95% CI 0.53–20.75). The results of sensitivity analyses were highly consistent with previous analyses.COT plus UDCA was the optimal UDCA-based regimen for both MOLT and AEs. BEF plus UDCA was most likely to cause AEs, whereas monotherapy with UDCA and coadministriation of COT plus UDCA appeared to be associated with the fewest AEs for PBC treatment. 相似文献
38.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
39.
40.